A Turbulent Year in the Publishing World

In 2017, scientists, regulators, and publishers clashed in a series of lawsuits, boycotts, mass resignations, and more.

Written byDiana Kwon
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

ISTOCK, ERHUI1979As subscription prices soar, preprints rise, and open access spreads, conflicts have ignited across the publishing world. Here is The Scientist’s roundup of events that made headlines this year.

This year, two major publishers, Elsevier and the American Chemical Society (ACS), won their lawsuits against Sci-Hub, a popular pirate website for academic papers. A New York district court awarded Elsevier a default legal judgement in June, ordering the site to pay $15 million in damages. In November, a judge in a Virginia district court ruled in favor of ACS, awarding it $4.8 million in damages and issuing a broad injunction that allows the society to demand that Internet service providers (ISPs), domain name registries, and search engines associated with the site censor it.

Some scientists and members of the technology sector and have raised concerns about the latter request. “[This] was a very important, unprecedented, and, I think, mistaken judgement made by the court ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies